Ask the Experts: Nephrology
Medscape's Ask the Experts allows you to ask members of a panel of leading experts for advice or information. You also have the opportunity to share your own views and insights by clicking the "Discuss this" link at the top of each response.
Ask the Experts
- Anemia Treatment Recommendations and Quality of Life in Renal Transplant Recipients
- Anemia Requiring Blood Transfusions in a Renal Transplant Recipient
- Resistant Anemia in a Renal Transplant Recipient
- What Is the Target Hemoglobin Concentration for the Chronic Kidney Disease Patient With Heart Disease?
- Anemia Differences Between CKD Patients and Renal Transplant Recipients
- Hemoglobin Variability in Anemia of Chronic Kidney Disease
- Provision of and Reimbursement for Erythropoietin for Patients Who Cannot Afford To Pay for It
- Optimal Dosing of Erythropoiesis-Stimulating Agents
- Combining Erythropoiesis-Stimulating Agents for Treatment of Anemia in Chronic Kidney Disease
- Correction of Anemia in Chronic Renal Failure
- Normalization of Hemoglobin Level in Patients With Chronic Kidney Disease and Anemia
- Vitamin C in the Management of Erythropoetin-resistant Anemia in Chronic Kidney Disease
- Levocarnitine in the Management of Epoetin-resistant Anemia in Chronic Kidney Disease
- Requirement for Iron Therapy in Hemodialysis Patients Receiving Erythropoietin
- Progression of Chronic Kidney Disease in a Nondiabetic, Well-Controlled Patient
- Erythropoietin Therapy in Diabetics
- Recommendations for Beginning Treatment of Anemia of Chronic Kidney Disease
- When To Begin Treatment With Human Erythropoietin in Patient With Chronic Kidney Disease
- Requirement for Iron Therapy in Hemodialysis Patients Receiving Erythropoietin
- Peritoneal Membrane
Disclaimer
The information in this web site reflects the views of the authors only and not Medscape. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers should verify all information and data before treating patients or utilizing any therapies noted in this program.
Ask a Question
Ask a Question
Ask Medscape's Expert Panel Clinical Questions on the following topics:
Expert Panel
- Daniel W. Coyne, MD, Professor of Medicine, Washington University, St. Louis, Missouri
William F. Finn, MD, Professor of Medicine, Department of Medicine, University of North Carolina School of Medicine; Attending Physician, The University of North Carolina Hospitals, Chapel Hill, North Carolina.- Steven Fishbane, MD, Chief of Nephrology, Winthrop-University Hospital, Mineola, New York; Professor of Medicine, SUNY, Stony Brook School of Medicine, Stony Brook, New York
Sandra L. Gadson, MD, Immediate Past President, National Medical Association, Washington, DC
Joanna Q. Hudson, PharmD, Associate Professor, Department of Clinical Pharmacy, Assistant Professor, Department of Medicine (Nephrology), University of Tennessee Health Science Center, Memphis, Tennessee; Clinical Pharmacist, Methodist University Hospital, Memphis, Tennessee
Francisco Llach, MD, Professor of Medicine, Nephrology, Georgetown University, Director, Clinical Nephrology, Georgetown University Hospital, Washington, DC.
Suanne Petroff, MSN, CKD Program Director, Western New England Renal and Transplant Association, Springfield, Massachusetts; Director of Clinical Staff, Western New England Renal and Transplant Association, Springfield, Massachusetts
Richard A. Sherman, MD, Professor of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School; Director, End Stage Renal Disease Services, Robert Wood Johnson University Hospital, New Brunswick, New Jersey.
Ajay K. Singh, MB, MRCP, Clinical Director, Renal Division; Director, Dialysis Services, Brigham and Women's Hospital, Boston, Massachusetts; Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts